Oh Young Bang

Summary

Affiliation: Sungkyunkwan University School of Medicine
Country: Korea

Publications

  1. Chung J, Bang O, Ahn K, Park S, Park T, Kim J, et al. Air Pollution Is Associated With Ischemic Stroke via Cardiogenic Embolism. Stroke. 2017;48:17-23 pubmed publisher
    ..Public and environmental health policies to reduce air pollution could help slow down global increasing trends of cardioembolic stroke. ..
  2. Moon G, Sung J, Kim D, Kim E, Cho Y, Son J, et al. Application of Mesenchymal Stem Cell-Derived Extracellular Vesicles for Stroke: Biodistribution and MicroRNA Study. Transl Stroke Res. 2018;: pubmed publisher
    ..MSC-EVs represent an ideal alternative to MSCs for stroke treatment, with similar medicinal capacity but an improved safety profile that overcomes cell-associated limitations in stem cell therapy. ..
  3. Shin J, Chung J, Park M, Lee H, Cha J, Seo W, et al. Outcomes after ischemic stroke caused by intracranial atherosclerosis vs dissection. Neurology. 2018;91:e1751-e1759 pubmed publisher
    ..94; 95% confidence interval, 3.32-19.01). Considering the high prevalence of ICAD in the patients with presumed ICAS and the differential outcomes between ICAD and ICAS, HR-MRI may be a useful diagnostic tool in this population. ..
  4. Chung J, Cho Y, Ahn M, Lee M, Kim G, Chung C, et al. Association of Cancer Cell Type and Extracellular Vesicles With Coagulopathy in Patients With Lung Cancer and Stroke. Stroke. 2018;49:1282-1285 pubmed publisher
    ..Our findings indicate that cancer cell type is associated with circulating EV levels and coagulopathy in patients with lung cancer and stroke. ..
  5. Jeong W, Choi J, Son J, Lee S, Lee M, Choe Y, et al. Volume and morphology of left atrial appendage as determinants of stroke subtype in patients with atrial fibrillation. Heart Rhythm. 2016;13:820-7 pubmed publisher
    ..In patients with AF, LAA orifice diameter and LAA volume, but not left atrial dysfunction, were determinants of CES and were useful for stratifying noncardioembolic risk in patients with AF. ..
  6. Bang O. Clinical Trials of Adult Stem Cell Therapy in Patients with Ischemic Stroke. J Clin Neurol. 2016;12:14-20 pubmed publisher
    ..This review presents the status of our understanding of adult stem cells and results from clinical trials, and introduces ongoing clinical studies of adult stem cell therapy in the field of stroke. ..
  7. Chung J, Bang O, Lee M, Hwang J, Cha J, Choi J, et al. Echoing Plaque Activity of the Coronary and Intracranial Arteries in Patients With Stroke. Stroke. 2016;47:1527-33 pubmed publisher
    ..Plaques within the intracranial and coronary arteries behave in similar ways. Our results suggest the need to evaluate and treat other vascular trees in patients with vulnerable plaques within a single arterial system. ..
  8. Chung J, Hwang J, Lee M, Cha J, Bang O. Previous Statin Use and High-Resolution Magnetic Resonance Imaging Characteristics of Intracranial Atherosclerotic Plaque: The Intensive Statin Treatment in Acute Ischemic Stroke Patients With Intracranial Atherosclerosis Study. Stroke. 2016;47:1789-96 pubmed publisher
    ..012). Premorbid statin usage is independently associated with reduced plaque enhancement and a decrease in large cortical lesions in patients with intracranial atherosclerotic stroke. ..
  9. Lee M, Son J, Kim S, Ryoo S, Woo S, Cha J, et al. Predicting Collateral Status With Magnetic Resonance Perfusion Parameters: Probabilistic Approach With a Tmax-Derived Prediction Model. Stroke. 2015;46:2800-7 pubmed publisher
    ..030). Collateral status is associated with more severe Tmax delays than previously defined. The present Tmax severity-weighted model can determine good collaterals and subsequent infarct growth. ..

More Information

Publications20

  1. Cha J, Shin E, Sung J, Moon G, Kim E, Cho Y, et al. Efficient scalable production of therapeutic microvesicles derived from human mesenchymal stem cells. Sci Rep. 2018;8:1171 pubmed publisher
    ..Our results may facilitate diverse applications of MSC-derived MVs from the bench to the bedside, which requires the large-scale production of MVs. ..
  2. Ryoo S, Lee M, Cha J, Jeon P, Bang O. Differential Vascular Pathophysiologic Types of Intracranial Atherosclerotic Stroke: A High-Resolution Wall Magnetic Resonance Imaging Study. Stroke. 2015;46:2815-21 pubmed publisher
    ..Our data indicate that BOD is a common and unique form of ICAS, distinct from non-BOD. These 2 types of ICAS have different vascular pathophysiologies in terms of vascular remodeling and plaque characteristics. ..
  3. Ryoo S, Chung J, Lee M, Kim S, Lee J, Kim G, et al. An Approach to Working Up Cases of Embolic Stroke of Undetermined Source. J Am Heart Assoc. 2016;5:e002975 pubmed publisher
    ..78). Our data indicate that patients with cryptogenic embolic stroke show distinct clinical and radiological features depending on the underlying causes. ..
  4. Bang O. Considerations When Subtyping Ischemic Stroke in Asian Patients. J Clin Neurol. 2016;12:129-36 pubmed publisher
  5. Bang O, Chung J, Ryoo S, Moon G, Kim G, Chung C, et al. Brain microangiopathy and macroangiopathy share common risk factors and biomarkers. Atherosclerosis. 2016;246:71-7 pubmed publisher
    ..Mild to moderate loss of renal function is strongly associated with both intracranial microangiopathy and macroangiopathy. Endothelial dysfunction may be associated with this relationship. ..
  6. Kim D, Son J, Yeon J, Kim G, Kim J, Hong S, et al. Infarct Pattern and Collateral Status in Adult Moyamoya Disease: A Multimodal Magnetic Resonance Imaging Study. Stroke. 2017;48:111-116 pubmed publisher
    ..Therapeutic strategies against thromboembolism, as well as collateral enhancing strategies targeting improvement of hemodynamic status or increased washout of emboli, are warranted. ..
  7. Park Y, Lee M, Kim J, Lee J, Park R, Kim G, et al. Genetic and Non-Genetic Factors Affecting the Quality of Anticoagulation Control and Vascular Events in Atrial Fibrillation. J Stroke Cerebrovasc Dis. 2017;26:1383-1390 pubmed publisher
    ..However, clinical events were more strongly associated with patient characteristics and clinical efforts than with genetic factors. ..
  8. Bang O, Moon G, Kim D, Lee J, Kim S, Son J, et al. Stroke Induces Mesenchymal Stem Cell Migration to Infarcted Brain Areas Via CXCR4 and C-Met Signaling. Transl Stroke Res. 2017;: pubmed publisher
    ..Culture expansion using the serum from stroke patients could constitute a novel preconditioning method to enhance the therapeutic efficiency of mesenchymal stem cells. ..
  9. Chung J, Seo W, Kim G, Chung C, Lee K, Bang O. Free fatty acid as a determinant of ischemic lesion volume in nonarterial-origin embolic stroke. J Neurol Sci. 2017;382:116-121 pubmed publisher
  10. request reprint
    Bang O, Chung J, Kim S, Oh M, Kim S, Cho Y, et al. Caveolin-1, Ring finger protein 213, and endothelial function in Moyamoya disease. Int J Stroke. 2016;11:999-1008 pubmed
    ..Our results suggest that Moyamoya disease is a caveolae disorder but is not related to endothelial dysfunction or dysregulation of circulating cytokines. ..
  11. Ryu J, Bang O, Lee G. D-dimer levels and cerebral infarction in critically ill cancer patients. BMC Cancer. 2017;17:591 pubmed publisher
    ..89 μg/mL) were only associated with cryptogenic stroke (adjusted OR 5.46; 95% confidence interval, 1.876-15.857). Abnormal D-dimer levels may support the diagnosis of cryptogenic stroke in critically ill cancer patients. ..